Company · CIK 0001006281 · SIC 2836 — Biological Products, (No Diagnostic Substances) · NYSE
Protalix BioTherapeutics, Inc. · PLX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 AForm 4 → | Sep 9, 5:00 pm EDT | Aharon SchwartzDirector | 25,500 | — | — | 8,500 | — | late |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Yaron NaosSr. VP & COO | 168,000 | — | — | 56,000 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Christian ElzeDirector | 25,500 | — | — | 8,500 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Gwen A MelincoffDirector | 25,500 | — | — | 8,500 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Pol F BoudesDirector | 25,500 | — | — | 8,500 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Dror BashanPRESIDENT AND CEO, Director | 480,000 | — | — | 160,000 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Amos Bar-ShalevDirector | 25,500 | — | — | 8,500 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Zvi Shmuel BenDirector | 25,500 | — | — | 8,500 | — | |
| Sep 3, 2026 AForm 4 → | Sep 4, 6:00 am EDT | Eliot ForsterDirector | 25,500 | — | — | 8,500 | — |